|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 91 - 120 of 193 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Itsehoito
|
Imodium 2 mg kapseli, pehmeä SPC 2023-01-10
|
|
PL
|
Itsehoito
|
Imodium 2 mg tabletti, kalvopäällysteinen SPC 2023-01-10
|
|
PL
|
Itsehoito
|
Imodium 2 mg tabletti, suussa hajoava SPC 2024-04-17
|
|
PL
|
Itsehoito
|
Imodium Plus 2 mg-125 mg tabletti SPC 2023-02-03
|
|
PL
|
Resepti
|
Imovane 5 mg, 7.5 mg tabletti, kalvopäällysteinen SPC 2022-11-08
|
|
PL
|
Resepti
|
Imovax Polio injektioneste, suspensio SPC 2023-04-19
|
|
|
|
European Medicines Agency's website:
Imraldi - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Imurel 25 mg, 50 mg tabletti, kalvopäällysteinen SPC 2023-10-12
|
|
|
|
European Medicines Agency's website:
Imvanex - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Inaqovi - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Inbrija - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Incellipan - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Increlex - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Incresync - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Indapamide Orion 1,5 mg depottabletti SPC 2022-06-08
|
|
PL
|
Resepti
|
Indium 111In DTPA 37 MBq-ml injektioneste, SPC 2021-10-29
|
|
PL
|
Resepti
|
Indium In-111 Chloride 370 MBq-ml kantaliuos radioaktiivista lääkettä varten SPC 2021-11-08
|
|
PL
|
Resepti
|
Indium In-111 Oxinate 37 MBq-ml kantaliuos radioaktiivista lääkettä varten SPC 2021-11-08
|
|
PL
|
Resepti
|
Indivina 1 mg- 2,5 mg, 1 mg - 5 mg, 2 mg - 5 mg tabletti SPC 2023-06-13
|
|
PL
|
Resepti
|
Indometin 50 mg kapseli, kova SPC 2022-09-26
|
|
|
|
European Medicines Agency's website:
Inductos - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Infanrix Hexa - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Infanrix-Polio injektioneste, suspensio, esitäytetty ruisku SPC 2023-04-26
|
|
PL
|
Resepti
|
Infanrix-Polio+Hib injektiokuiva-aine ja suspensio, suspensiota varten SPC 2023-04-26
|
|
|
|
European Medicines Agency's website:
Inflectra - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Influvac injektioneste, suspensio, esitäytetty ruisku SPC 2024-07-24
|
|
PL
|
Resepti
|
Influvac Tetra injektioneste, suspensio, esitäytetty ruisku SPC 2024-04-02
|
|
|
|
European Medicines Agency's website:
Inhixa - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Injektionesteisiin käytettävä vesi CSL Behring SPC 2022-02-08
|
|
PL
|
Resepti
|
Injexate 50 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2024-07-24
|
|
|
| |
